Anti-KIF17 monoclonal antibody

Pre-made anti-KIF17 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to KIF17/KIF17 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2560-Ab-1/ GM-Tg-hg-IP2560-Ab-2Anti-Human KIF17 monoclonal antibodyHuman
GM-Tg-rg-IP2560-Ab-1/ GM-Tg-rg-IP2560-Ab-2Anti-Rat KIF17 monoclonal antibodyRat
GM-Tg-mg-IP2560-Ab-1/ GM-Tg-mg-IP2560-Ab-2Anti-Mouse KIF17 monoclonal antibodyMouse
GM-Tg-cynog-IP2560-Ab-1/ GM-Tg-cynog-IP2560-Ab-2Anti-Cynomolgus/ Rhesus macaque KIF17 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2560-Ab-1/ GM-Tg-felg-IP2560-Ab-2Anti-Feline KIF17 monoclonal antibodyFeline
GM-Tg-cang-IP2560-Ab-1/ GM-Tg-cang-IP2560-Ab-2Anti-Canine KIF17 monoclonal antibodyCanine
GM-Tg-bovg-IP2560-Ab-1/ GM-Tg-bovg-IP2560-Ab-2Anti-Bovine KIF17 monoclonal antibodyBovine
GM-Tg-equg-IP2560-Ab-1/ GM-Tg-equg-IP2560-Ab-2Anti-Equine KIF17 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2560-Ab-1/ GM-Tg-hg-IP2560-Ab-2; GM-Tg-rg-IP2560-Ab-1/ GM-Tg-rg-IP2560-Ab-2;
GM-Tg-mg-IP2560-Ab-1/ GM-Tg-mg-IP2560-Ab-2; GM-Tg-cynog-IP2560-Ab-1/ GM-Tg-cynog-IP2560-Ab-2;
GM-Tg-felg-IP2560-Ab-1/ GM-Tg-felg-IP2560-Ab-2; GM-Tg-cang-IP2560-Ab-1/ GM-Tg-cang-IP2560-Ab-2;
GM-Tg-bovg-IP2560-Ab-1/ GM-Tg-bovg-IP2560-Ab-2; GM-Tg-equg-IP2560-Ab-1/ GM-Tg-equg-IP2560-Ab-2
Products NameAnti-KIF17 monoclonal antibody
Formatmab
Target NameKIF17
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-KIF17 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2560-Ag-1Recombinant multi-species KIF17/ KIF17B/ KIF3X protein
    ORF Viral VectorpGMLP002256human KIF17 Lentivirus plasmid
    ORF Viral VectorvGMLP002256human KIF17 Lentivirus particle


    Target information

    Target IDGM-IP2560
    Target NameKIF17
    Gene ID57576,16559,500571,717482,100688382,101093285,530435,100058362
    Gene Symbol and Synonyms5930435E01Rik,KIF17,KIF17B,KIF3X,KLP-2,mKIAA1405,OSM-3,RGD1562511
    Uniprot AccessionQ9P2E2
    Uniprot Entry NameKIF17_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000117245
    Target ClassificationN/A

    The target: KIF17, gene name: KIF17, also named as KIF17B, KIF3X, KLP-2, OSM-3. Predicted to enable microtubule binding activity and plus-end-directed microtubule motor activity. Predicted to be involved in anterograde dendritic transport of neurotransmitter receptor complex and cell projection organization. Predicted to act upstream of or within microtubule-based process; protein-containing complex localization; and vesicle-mediated transport. Predicted to be located in microtubule cytoskeleton. Predicted to be part of intraciliary transport particle B and kinesin complex. Predicted to be active in cilium; microtubule cytoskeleton; and neuron projection. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.